These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

853 related articles for article (PubMed ID: 27716745)

  • 1. The degradation of EZH2 mediated by lncRNA ANCR attenuated the invasion and metastasis of breast cancer.
    Li Z; Hou P; Fan D; Dong M; Ma M; Li H; Yao R; Li Y; Wang G; Geng P; Mihretab A; Liu D; Zhang Y; Huang B; Lu J
    Cell Death Differ; 2017 Jan; 24(1):59-71. PubMed ID: 27716745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA-ANCR regulates the cell growth of osteosarcoma by interacting with EZH2 and affecting the expression of p21 and p27.
    Zhang F; Peng H
    J Orthop Surg Res; 2017 Jul; 12(1):103. PubMed ID: 28679390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA anti-differentiation non-coding RNA affects proliferation, invasion, and migration of breast cancer cells by targeting miR-331.
    Jiang C; Shi X; Yi D; Wang R; Xu F; Guan W; Sang J
    Bioengineered; 2021 Dec; 12(2):12236-12245. PubMed ID: 34783641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA-ANCR down-regulation suppresses invasion and migration of colorectal cancer cells by regulating EZH2 expression.
    Yang ZY; Yang F; Zhang YL; Liu B; Wang M; Hong X; Yu Y; Zhou YH; Zeng H
    Cancer Biomark; 2017; 18(1):95-104. PubMed ID: 27983539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The long non-coding RNA DANCR regulates the inflammatory phenotype of breast cancer cells and promotes breast cancer progression via EZH2-dependent suppression of SOCS3 transcription.
    Zhang KJ; Tan XL; Guo L
    Mol Oncol; 2020 Feb; 14(2):309-328. PubMed ID: 31860165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M; Zhang XY; Yu X
    Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA ANCR promotes glioma cells invasion, migration, proliferation and inhibits apoptosis via interacting with EZH2 and repressing PTEN expression.
    Cheng C; Dong Y; Ru X; Xia Y; Ji Y
    Cancer Gene Ther; 2021 Sep; 28(9):1025-1034. PubMed ID: 33293663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing of LncRNA-ANCR Promotes the Osteogenesis of Osteoblast Cells in Postmenopausal Osteoporosis via Targeting EZH2 and RUNX2.
    Cai N; Li C; Wang F
    Yonsei Med J; 2019 Aug; 60(8):751-759. PubMed ID: 31347330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repression of PDK1- and LncRNA HOTAIR-Mediated EZH2 Gene Expression Contributes to the Enhancement of Atractylenolide 1 and Erlotinib in the Inhibition of Human Lung Cancer Cells.
    Xiao Q; Zheng F; Tang Q; Wu JJ; Xie J; Huang HD; Yang XB; Hann SS
    Cell Physiol Biochem; 2018; 49(4):1615-1632. PubMed ID: 30223276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of Long Noncoding RNA HOTAIR and EZH2 Induces Apoptosis and Inhibits Proliferation, Invasion, and Migration of Human Breast Cancer Cells.
    Han L; Zhang HC; Li L; Li CX; Di X; Qu X
    Cancer Biother Radiopharm; 2018 Aug; 33(6):241-251. PubMed ID: 30048163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of long noncoding RNA FERRE promoted growth and invasion of breast cancer through modulating miR-19a-5p/EZH2 axis.
    Lin Y; Wu T; Yang M; Duangmano S; Chaiwongsa R; Pornprasert S; He T
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11154-11164. PubMed ID: 33215433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA ANCR Promotes Invasion and Migration of Gastric Cancer by Regulating FoxO1 Expression to Inhibit Macrophage M1 Polarization.
    Xie C; Guo Y; Lou S
    Dig Dis Sci; 2020 Oct; 65(10):2863-2872. PubMed ID: 31894487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA H19 promotes epithelial mesenchymal transition and metastasis of esophageal cancer via STAT3/EZH2 axis.
    Chen MJ; Deng J; Chen C; Hu W; Yuan YC; Xia ZK
    Int J Biochem Cell Biol; 2019 Aug; 113():27-36. PubMed ID: 31102664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA DLG5-AS1 facilitates breast cancer cell proliferation and invasion by promoting EZH2-mediated transcriptional silencing of SFRP1.
    Cai Y; Liu Y; Sun Y; Ren Y
    Arch Biochem Biophys; 2024 Jun; 756():110018. PubMed ID: 38677505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation of EZH2 by PRMT1 regulates its stability and promotes breast cancer metastasis.
    Li Z; Wang D; Lu J; Huang B; Wang Y; Dong M; Fan D; Li H; Gao Y; Hou P; Li M; Liu H; Pan ZQ; Zheng J; Bai J
    Cell Death Differ; 2020 Dec; 27(12):3226-3242. PubMed ID: 32895488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells.
    Li W; Sun M; Zang C; Ma P; He J; Zhang M; Huang Z; Ding Y; Shu Y
    Cell Death Dis; 2016 May; 7(5):e2225. PubMed ID: 27195672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA cancer susceptibility candidate 9 promotes doxorubicin‑resistant breast cancer by binding to enhancer of zeste homolog 2.
    Jiang B; Li Y; Qu X; Zhu H; Tan Y; Fan Q; Jiang Y; Liao M; Wu X
    Int J Mol Med; 2018 Nov; 42(5):2801-2810. PubMed ID: 30106089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LincK contributes to breast tumorigenesis by promoting proliferation and epithelial-to-mesenchymal transition.
    Li J; Hao Y; Mao W; Xue X; Xu P; Liu L; Yuan J; Zhang D; Li N; Chen H; Zhao L; Sun Z; Luo J; Chen R; Zhao RC
    J Hematol Oncol; 2019 Feb; 12(1):19. PubMed ID: 30795783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EZH2 promotes cell migration and invasion but not alters cell proliferation by suppressing E-cadherin, partly through association with MALAT-1 in pancreatic cancer.
    Han T; Jiao F; Hu H; Yuan C; Wang L; Jin ZL; Song WF; Wang LW
    Oncotarget; 2016 Mar; 7(10):11194-207. PubMed ID: 26848980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosome-transmitted lncRNA UFC1 promotes non-small-cell lung cancer progression by EZH2-mediated epigenetic silencing of PTEN expression.
    Zang X; Gu J; Zhang J; Shi H; Hou S; Xu X; Chen Y; Zhang Y; Mao F; Qian H; Zhu T; Xu W; Zhang X
    Cell Death Dis; 2020 Apr; 11(4):215. PubMed ID: 32242003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.